{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:16:46Z","timestamp":1780571806017,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.hroo.2022.09.011","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T12:55:59Z","timestamp":1663678559000},"page":"647-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"PA","title":["Economic Evaluation of Contact Force Catheter Ablation for Persistent Atrial Fibrillation in the United States"],"prefix":"10.1016","volume":"3","author":[{"given":"Jose","family":"Osorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Melby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4786-1401","authenticated-orcid":false,"given":"Ryan J.","family":"Imhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina D.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Maccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2022.09.011_bib1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2022.09.011_bib2","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1161\/CIR.0000000000000568","article-title":"Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association","volume":"137","author":"Chen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2022.09.011_bib3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1524-4733.2006.00124.x","article-title":"Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States","volume":"9","author":"Coyne","year":"2006","journal-title":"Value Health"},{"key":"10.1016\/j.hroo.2022.09.011_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","article-title":"Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis","volume":"55","author":"de Vos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2022.09.011_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10840-018-0349-8","article-title":"Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials","volume":"52","author":"Chen","year":"2018","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hroo.2022.09.011_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.hroo.2020.12.017","article-title":"Catheter ablation and health care utilization and cost among patients with paroxysmal versus persisten atrial fibrillation","volume":"2","author":"Friedman","year":"2021","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.hroo.2022.09.011_bib7","first-page":"99","article-title":"Mortality, stroke, and heart failure in atrial fibrillation cohorts after ablation versus propensity-matched cohorts","volume":"8","author":"Jarman","year":"2017","journal-title":"Pragmat Obs Res"},{"key":"10.1016\/j.hroo.2022.09.011_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12872-018-0946-6","article-title":"Resource use and clinical outcomes in patients with atrial fibrillation with ablation versus antiarrhythmic drug treatment","volume":"18","author":"Jarman","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hroo.2022.09.011_bib9","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/eurheartj\/ehu001","article-title":"The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association","volume":"35","author":"Arbelo","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2022.09.011_bib10","first-page":"958","article-title":"Persistent atrial fibrillation ablation with contact force sensing catheter: the prospective multicenter PRECEPT Trial","volume":"6","author":"Mansour","year":"2020","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.hroo.2022.09.011_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008867","article-title":"Positive clinical benefit on patient care, quality of life, and symptoms after contact force-guided radiofrequency ablation in persistent atrial fibrillation: analyses from the PRECEPT prospective multicenter study","volume":"14","author":"Natale","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2022.09.011_bib12","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.19102\/icrm.2019.100804","article-title":"Mortality and costs associated with wearable cardioverter-defibrillators after acute myocardial infarction: a retrospective cohort analysis of Medicare claims data","volume":"10","author":"Clark","year":"2019","journal-title":"J Innov Card Rhythm Manag"},{"key":"10.1016\/j.hroo.2022.09.011_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.resuscitation.2019.09.006","article-title":"Factors associated with return to work among survivors of out-of-hospital cardiac arrest","volume":"146","author":"Kearney","year":"2020","journal-title":"Resuscitation"},{"key":"10.1016\/j.hroo.2022.09.011_bib14","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehz085","article-title":"Atrial fibrillation ablation in practice: assessing CABANA generalizability","volume":"40","author":"Noseworthy","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2022.09.011_bib15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/13696998.2019.1603156","article-title":"Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants","volume":"22","author":"Rozjabek","year":"2019","journal-title":"J Med Econ"},{"key":"10.1016\/j.hroo.2022.09.011_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169759","article-title":"Return to work after a stroke in working age persons; a six-year follow up","volume":"12","author":"Westerlind","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.hroo.2022.09.011_bib26","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2022.09.011_bib27","author":"Pelech"},{"key":"10.1016\/j.hroo.2022.09.011_bib28","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jval.2012.04.014","article-title":"Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6","volume":"15","author":"Briggs","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.hroo.2022.09.011_bib29","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.hroo.2022.09.011_bib30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3111\/13696998.2014.911185","article-title":"Cost-effectiveness of the convergent procedure and catheter ablation for non-paroxysmal atrial fibrillation","volume":"17","author":"Anderson","year":"2014","journal-title":"J Med Econ"},{"key":"10.1016\/j.hroo.2022.09.011_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1540-8167.2011.02130.x","article-title":"Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation","volume":"23","author":"Ladapo","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2022.09.011_bib32","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1111\/jce.14189","article-title":"Economic impact of contact force sensing in catheter ablation for atrial fibrillation","volume":"30","author":"Mansour","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2022.09.011_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/JOM.0b013e31820fd1c9","article-title":"Economic impact to employers of treatment options for cardiac arrhythmias in the US health system","volume":"53","author":"Kleinman","year":"2011","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.hroo.2022.09.011_bib34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.122.058575","article-title":"Cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy in atrial fibrillation: the CABANA randomized clinical trial","volume":"146","author":"Chew","year":"2022","journal-title":"Circulation"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266650182200229X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266650182200229X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:25:29Z","timestamp":1762993529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266650182200229X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S266650182200229X"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2022.09.011","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic Evaluation of Contact Force Catheter Ablation for Persistent Atrial Fibrillation in the United States","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2022.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}